Compare ANPA & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANPA | LNSR |
|---|---|---|
| Founded | 2016 | 2004 |
| Country | Hong Kong | United States |
| Employees | 32 | N/A |
| Industry | | Medical Electronics |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.7M | 146.7M |
| IPO Year | N/A | 2005 |
| Metric | ANPA | LNSR |
|---|---|---|
| Price | $8.58 | $5.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 12.6K | ★ 108.1K |
| Earning Date | 02-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | N/A | $10.06 |
| Revenue Next Year | N/A | $41.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $2.80 | $5.19 |
| 52 Week High | $180.64 | $14.26 |
| Indicator | ANPA | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 35.75 | 29.03 |
| Support Level | $8.11 | N/A |
| Resistance Level | $9.43 | $6.39 |
| Average True Range (ATR) | 0.57 | 0.32 |
| MACD | 0.60 | 0.13 |
| Stochastic Oscillator | 13.31 | 3.85 |
Rich Sparkle Holdings Ltd is a holding company conducting its operations as a professional specialist in the provision of financial printing services such as printing, typesetting and translation, advisory services including Environmental, Social and Governance (ESG) and internal control reporting services and other services including standalone annual general meeting and extraordinary general meeting supporting service and other standalone services, through its sole operating subsidiary in Hong Kong. Its segments include Financial printing services such as printing, typesetting and translation, Advisory services including Environmental, Social and Governance Report and Other services.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.